• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受手术的胸膜间皮瘤患者的长期生存分析:来自三级转诊中心的简要报告

Long-Term Survival Analysis of Pleural Mesothelioma Patients Undergoing Surgery: Brief Report From a Tertiary Referral Centre.

作者信息

Orlandi Riccardo, Leuzzi Giovanni, Rolli Luigi, Ferrari Michele, Stanzi Alessia, Valsecchi Camilla, Pastorino Ugo

机构信息

Department of Thoracic Surgery, University of Milan, Milan, Italy.

Division of Thoracic Surgery, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy.

出版信息

Clin Lung Cancer. 2024 Jan;25(1):e5-e10. doi: 10.1016/j.cllc.2023.10.010. Epub 2023 Oct 24.

DOI:10.1016/j.cllc.2023.10.010
PMID:37980239
Abstract

OBJECTIVES

to date, no consensus has been reached on the surgical gold-standard in pleural mesothelioma (PM). We retrospectively reviewed our experience as a tertiary referral centre, to compare short- and long-term survival of PM patients undergoing different types of surgery.

METHODS

in retrospective, observational, single-centre study, we analysed all the patients histologically diagnosed with PM undergoing surgical procedures with palliative or curative intent at IRCCS Istituto Nazionale dei Tumori of Milan, Italy, from January 2003 to December 2020. The primary study endpoint was 10-year overall survival (OS) in three different types of resections: extra-pleural-pneumonectomy (EPP), pleurectomy/decortication (P/D), partial-pleurectomy/pleural-biopsy (PP/B). Secondary endpoints were postoperative hospital stay and postoperative 30-day and 90-day mortality rates. The survival function was estimated using Kaplan-Meier, and the Log-rank test was used for testing differences. Univariable and Multivariable Cox regression models were implemented to estimate Hazard Ratio (HR) for all variables of interest.

RESULTS

243 consecutive patients were enrolled, EPP was performed in 49 (20.2%), P/D in 58 (23.8%), PP/B in 136 (56.0%) patients. The median follow-up time was 19.8 months. 10-year OS was significantly better for P/D group (16%, Log-Rank test p<0.0001) compared to PP/B (1.8%) and EPP (0%). No statistically significant differences were found among the 3 surgical groups in 30- and 90-day mortality rates. At multivariable analysis, gender (male, HR=1.58), type of resection (P/D, HR=0.55) and surgery date (recent years, HR=0.61) were found to be independent prognostic factors for OS.

CONCLUSIONS

in PM, lung-sparing curative approach (e.g. P/D) should be preferred in highly selected patients and in highly experienced centres, whenever appropriate. Anyway, when P/D is not indicated, adopting palliative/conservative management (e.g. PP/B) could ensure comparable results as extremely aggressive surgeries (e.g. EPP). The aim of surgery in PM should not be reaching complete resection, but rather accomplishing significant resection allowing to complete the multimodality treatment in highly selected patients in experienced centers.

摘要

目的

迄今为止,关于胸膜间皮瘤(PM)的手术金标准尚未达成共识。我们回顾性分析了我们作为三级转诊中心的经验,以比较接受不同类型手术的PM患者的短期和长期生存率。

方法

在一项回顾性、观察性、单中心研究中,我们分析了2003年1月至2020年12月期间在意大利米兰IRCCS国家肿瘤研究所接受姑息性或根治性手术的所有经组织学诊断为PM的患者。主要研究终点是三种不同类型切除术的10年总生存率(OS):胸膜外全肺切除术(EPP)、胸膜剥脱术/去皮质术(P/D)、部分胸膜切除术/胸膜活检(PP/B)。次要终点是术后住院时间以及术后30天和90天死亡率。使用Kaplan-Meier法估计生存函数,并使用对数秩检验来检验差异。实施单变量和多变量Cox回归模型以估计所有感兴趣变量的风险比(HR)。

结果

连续纳入243例患者,49例(20.2%)接受了EPP,58例(23.8%)接受了P/D,136例(56.0%)接受了PP/B。中位随访时间为19.8个月。与PP/B组(1.8%)和EPP组(0%)相比,P/D组的10年总生存率显著更好(16%,对数秩检验p<0.0001)。3个手术组在30天和90天死亡率方面未发现统计学显著差异。在多变量分析中,性别(男性,HR=1.58)、切除类型(P/D,HR=0.55)和手术日期(近年来,HR=0.61)被发现是总生存率的独立预后因素。

结论

在PM中,对于经过严格筛选的患者以及经验丰富的中心,只要合适,应首选保留肺的根治性方法(如P/D)。无论如何,当不适合进行P/D时,采用姑息性/保守性治疗(如PP/B)可确保与极其激进的手术(如EPP)取得相当的结果。PM手术的目标不应是实现完全切除,而应是完成显著切除,以便在经验丰富的中心对经过严格筛选的患者完成多模式治疗。

相似文献

1
Long-Term Survival Analysis of Pleural Mesothelioma Patients Undergoing Surgery: Brief Report From a Tertiary Referral Centre.接受手术的胸膜间皮瘤患者的长期生存分析:来自三级转诊中心的简要报告
Clin Lung Cancer. 2024 Jan;25(1):e5-e10. doi: 10.1016/j.cllc.2023.10.010. Epub 2023 Oct 24.
2
Is Pleurectomy/Decortication Superior to Extrapleural Pneumonectomy for Patients with Malignant Pleural Mesothelioma? A Single-Institutional Experience.对于恶性胸膜间皮瘤患者,胸膜切除术/纤维板剥脱术是否优于胸膜外全肺切除术?一项单机构经验。
Ann Thorac Cardiovasc Surg. 2018 Apr 20;24(2):81-88. doi: 10.5761/atcs.oa.17-00192. Epub 2018 Jan 23.
3
Extrapleural Pneumonectomy Versus Pleurectomy/Decortication for Malignant Pleural Mesothelioma.胸膜外全肺切除术与胸膜剥脱/肺切除术治疗恶性胸膜间皮瘤。
Ann Thorac Surg. 2022 Jan;113(1):200-208. doi: 10.1016/j.athoracsur.2021.04.078. Epub 2021 May 8.
4
Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.胸膜外肺切除术与胸膜剥脱术/纤维板剥脱术治疗恶性胸膜间皮瘤的手术疗效:663例患者的结果
J Thorac Cardiovasc Surg. 2008 Mar;135(3):620-6, 626.e1-3. doi: 10.1016/j.jtcvs.2007.10.054. Epub 2008 Feb 14.
5
Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.根治性胸膜切除术和放化疗治疗恶性胸膜间皮瘤:不完全切除的结果。
Lung Cancer. 2013 Aug;81(2):241-6. doi: 10.1016/j.lungcan.2013.04.019. Epub 2013 May 17.
6
Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.胸膜切除术/剥除术优于胸膜外全肺切除术在恶性胸膜间皮瘤的多模式治疗。
J Thorac Oncol. 2012 Apr;7(4):737-43. doi: 10.1097/JTO.0b013e31824ab6c5.
7
Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma.恶性胸膜间皮瘤根治性手术患者的合并症、术后发病率及生存率
Eur J Cardiothorac Surg. 2016 Dec;50(6):1077-1082. doi: 10.1093/ejcts/ezw215. Epub 2016 Jun 21.
8
Surgical strategy for malignant pleural mesothelioma: the superiority of pleurectomy/decortication.恶性胸膜间皮瘤的外科治疗策略:胸膜切除术/剥脱术的优势。
Surg Today. 2022 Jul;52(7):1031-1038. doi: 10.1007/s00595-021-02437-9. Epub 2022 Jan 19.
9
National Cancer Database Report on Pneumonectomy Versus Lung-Sparing Surgery for Malignant Pleural Mesothelioma.国家癌症数据库报告:肺切除术与肺保留手术治疗恶性胸膜间皮瘤的比较。
J Thorac Oncol. 2017 Nov;12(11):1704-1714. doi: 10.1016/j.jtho.2017.08.012. Epub 2017 Aug 24.
10
Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy.与剖胸去顶术相比,双侧胸腔廓清术联合滑石粉胸膜固定术治疗恶性胸膜间皮瘤的患者生存获益更好。
J Thorac Cardiovasc Surg. 2023 May;165(5):1722-1730. doi: 10.1016/j.jtcvs.2022.11.035. Epub 2022 Dec 14.

引用本文的文献

1
Three-dimensional printing of the human lung pleural cavity model for PDT malignant mesothelioma.用于光动力疗法治疗恶性间皮瘤的人体肺胸膜腔模型的三维打印
Photodiagnosis Photodyn Ther. 2024 Apr;46:104014. doi: 10.1016/j.pdpdt.2024.104014. Epub 2024 Feb 10.